A retrospective cohort analysis of factors influencing continuous antibiotic therapy with ampicillin
Authors:
Open Access
- 23 October 2024
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 358, 123168
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With SepsisJAMA, 2024
- Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With SepsisJAMA, 2023
- Do Prolonged Infusions of β-Lactam Antibiotics Improve Outcomes in Critically Ill Patients With Sepsis?JAMA, 2023
- Evaluation of continuous ampicillin/sulbactam infusion in critically ill patientsLife Sciences, 2023
- Population Pharmacokinetics and Dosing Simulations of Ampicillin and Sulbactam in Hospitalised Adult PatientsClinical Pharmacokinetics, 2023
- New Creatinine- and Cystatin C–Based Equations to Estimate GFR without RaceNew England Journal of Medicine, 2021
- Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie – Update 2021Pneumologie, 2021
- Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#Intensive Care Medicine, 2020
- Contemporaneous management of ampicillin infusions in the outpatient setting through the use of therapeutic drug monitoringInternational Journal of Antimicrobial Agents, 2020
- Continuous ampicillin infusion as an alternative to intermittent infusion for adult inpatients: A case seriesJournal of Infection and Chemotherapy, 2014